Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Ruxolitinib treatment may cause eyelash growth.

BMS-470539 reduces skin fibrosis and inflammation.

Azithromycin and Roxithromycin can remove aging cells and may help with anti-aging.

Janus Kinase inhibitors are effective and safe for treating alopecia areata, but more research is needed.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Sonidegib and vismodegib have different side effects and reporting patterns.

Minoxidil needs specific structure to block lysyl hydroxylase; exploring alternatives may keep benefits without this effect.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

Ruxolitinib can cause a delayed skin reaction on the nose.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

JAK inhibitors are effective for treating alopecia areata, with most patients seeing hair growth after treatment.

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

New molecules can prevent cell death in hair follicles.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.